Understand why pharmaceutical developers are increasingly asked by regulators to include imaging analysis when evaluating clinical trial data.
The webinar will focus on these issues and the competitive edge metrics provide those organizations engaged in conducting clinical trials.
In this 2017 eCOA Forum video session, Dr. Bill Byrom, Senior Director of Product Innovation at ICON, uses case studies to present patient attitudes towards BYOD, technical challenges encountered and measurement equivalence considerations.
In this brief interview, ERT’s President and CEO Jim Corrigan discusses the risks associated with clinical trials, clearing the hurdle of paper in clinical research, the most promising and exciting advancements in the eclinical space, where the eclinical space will be five years from now, and the new era of collaboration.
Informed consent is the essential start to your complex and often lengthy clinical trial. However, the process goes far beyond obtaining a signature from your participants.
In this 3 minute video, learn about TrialConsentTM, CRF Health's intuitive electronic platform for designing, collecting and managing the specific needs of your informed consent process.
Is using eCOA as simple as using an ATM machine? In this two-minute video, eCOA subject matter expert and Senior Scientific Advisor, Dr. Jill Platko, addresses how to design an eCOA solution for senior populations. What needs to be considered? Is it different from designing for other populations?
A common myth about electronic informed consent (eConsent) is that senior populations will have trouble using it. CRF Health research proves just the opposite -- in fact, seniors were more likely to adopt and use electronic over paper due to its numerous benefits.
In this short video, informed consent industry expert, Sandra "SAM" Sather, discusses the Food and Drug Administration's 2016 final guidance document for eConsent, "Use of Electronic Informed Consent." Learn how the FDA supports Electronic Informed Consent and how it can be used to improve patient compliance and comprehension.
Presenters: Naor Chazan, Director of Marketing (but no longer with the company, FYI) and Sandra “SAM” Sather, Quality and Regulatory, TrialConsent) CRF Health's State of eConsent 2017 Report surveyed 100 biotech, pharmaceutical, CRO, and IRB organizations who shared their opinions on Electronic Informed Consent (eConsent). During this webinar, industry expert, Sandra "Sam" Sather, Regulatory and Quality Lead for TrialConsentTM at CRF Health, discusses the results.
Many researchers have complained that use of different local IRBs to review each research site for a multicenter trial is extremely inefficient and leads to additional cost burdens and trial delays. Despite this, many US research sites have been hesitant to use a single, central IRB. Is there a substantive difference, in terms of efficiency and effectiveness, between reviews conducted by decentralized (local) and centralized IRBs? What are the pros and cons of each? Are local IRBs really even necessary, or do they just create bottlenecks in modern clinical trials? The webinar will focus on these issues and look at study startup metrics associated with IRBs.
|
|
|
|
|
|
|
|
|